Epidemiology and Survival Outcomes of Synchronous and Metachronous Brain Metastases: A Retrospective Population-Based Study

Neurosurgeons Chetan Bettegowda and Jordina Rincon-Torroella discuss results from their retrospective study about the incidence and survival outcomes of brain metastases over the past decade. Using data from the TriNetX Diamond Network and diagnoses and therapies identified with ICD-10 and CPT codes, they found (1) a substantial rate of brain metastases present within 2-6 months of primary cancer, which may guide future recommendations on intracranial staging, and (2) antineoplastic and radiation therapy prior to the development of brain metastases may prolong time before metastasis and improve survival.

Related Presenters

Chetan Bettegowda, MD, PhD.

Chetan Bettegowda, MD, PhD

Professor of Neurological Surgery

Director, Meningioma Center Professor of Neurosurgery   Languages: English, Kannada  Expertise: Brain Tumors, CyberKnife and stereotactic radiosurgery, Gliomas, Meningiomas, Metastatic Brain Tumors, Neurosurgery, Pituitary Tumors, Skull ...

View full profile

Jordina Rincon Torroella, M.D..

Jordina Rincon Torroella, M.D.

Assistant Professor of Neurosurgery

Jordina Rincon-Torroella is a fellowship-trained neurosurgeon specializing in the surgical treatment of benign and malignant tumors of the brain and skull base, such as meningiomas, gliomas, pituitary tumors and metastatic brain tumors, ...

View full profile


Related Videos